Fred Hutchinson Cancer Research Center

The Fred Hutchinson Cancer Research Center, home of three Nobel Prize laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical technology to eliminate cancer and related diseases as causes of human suffering and death. Fred Hutchinson receives more funding from the National Institutes of Health than any other independent U.S. research center. Recognized internationally for its pioneering work in bone-marrow transplantation, the center’s five scientific divisions collaborate to form a unique environment for conducting basic and applied science. Fred Hutchinson is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest and is one of 41 nationwide.

University of Washington

University of Washington

The University of Washington’s faculty includes five Nobel Prize-winners, five MacArthur Fellows, and more than 40 members of the prestigious National Academy of Sciences. Its highly regarded School of Medicine has been ranked first in the nation in training primary-care physicians, and several of its graduate and professional programs are rated among the top 10 in their fields. Since 1975, the UW has been among the top public universities in receipt of federal research funds.

Vancouver Prostate Centre

The Vancouver Prostate Centre, an affiliate of the University of British Columbia, is the largest comprehensive research and treatment centre of its kind in Canada with a focus exclusively on prostate disease. Home to Canada’s largest gene array facility and Western Canada’s only Training and Education Centre for Prostate Research, the Centre is a University of British Columbia Academic Centre of Excellence. The Vancouver Prostate Centre is one of three centres of excellence located at Vancouver General Hospital (VGH). VGH is the primary adult referral and teaching hospital in Western Canada and is part of the Vancouver Coastal Health Authority, the largest network of health organizations and services in Canada. and

Oregon Health and Science University Knight Cancer Institute

Founded in 1992 as the Oregon Cancer Center, the Knight Cancer Institute changed its name in 2008 following a transformational gift from Nike founder Phil Knight and his wife, Penny. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle. The institute is known internationally for its leadership in fighting cancer at the molecular level. The most celebrated cancer discovery in a generation—the targeted drug Gleevec—was developed at OHSU by Brian J. Druker, M.D., the director of the OHSU Knight Cancer Institute and JELD-WEN Chair of Leukemia Research. Druker also is a member of the National Academy of Sciences and a Howard Hughes Medical Investigator. Members of four scientific programs (Cancer Biology, Hematologic Malignancies, Solid Tumor, and Cancer Prevention and Control) utilize eight well-established shared resources to perform outstanding research, convert research findings into treatments and preventive agents, and design clinical trials to validate molecular targets in the clinic. Embedded within the Solid Tumors program is the Prostate Cancer Focus Group. The group consists of more than 20 investigators who pursue clinical, translational and basic research that tackles a broad range of challenges specific to prostate cancer. Collaborations between prostate cancer investigators at OHSU and those at FHCRC/UWMC have developed over the past ten years, initially through joint efforts in clinical trials development and patient education, and more recently through translational scientific efforts. and